Beckman Coulter Life Sciences Launches Cytobank v10 Platform

Beckman Coulter Life Sciences Launches Cytobank v10 Platform

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, introduces an automated solution to the grueling and time-consuming process of manually gating flow cytometry data that requires no programming skills. This revolutionary feature is part of the new Cytobank v10 platform upgrade, now available.

Inconsistency between operators has been identified as one of the main factors contributing to variability in the analysis of flow cytometry data. Cytobank Automatic Gating can solve this problem and reduce variability compared to manual gating. Depending on the complexity of the gating strategy, automatic gating of Cytobank can take up to 75% less time compared to manual gating of the full population identification dataset.

When customers talk, we listen, and we've heard a lot about the reproducibility crisis in biomedical research, along with the struggles that come with inconsistencies caused by manual gating. Gating files manually is tedious and time-consuming, especially for large and complex panels or datasets with many files. Lab staff can spend hours or sometimes even days adjusting gates. We have been relentless in our mission to stop the madness and provide a solution to these challenges so customers can improve their flow cytometry data analysis without having to be programmers.”

Nicole Weit, Senior Technical Product Manager, Biodiscovery Flow Software.

Cytobank's automatic gating allows lab staff to set their own gating strategy on a set of files, train a model, and then reproducibly analyze additional samples using the trained model. The trained model can then be easily shared with colleagues around the world. This two-step workflow saves users hands-on time, reduces variability, and enables collaboration across institutions. When new data needs to be analyzed, users simply start a new automatic gating inference run with the trained model.

The Cytobank platform is a cloud-based analysis solution for cytometry data and offers powerful visual data management and controlled data exchange. By providing access to machine learning-powered analysis without requiring any coding or coding skills, the Cytobank platform helps researchers gain new insights from high-dimensional data using unbiased approaches that reduce reproducibility issues and eliminate operator-dependent bias.

86% of users will recommend the Cytobank platform as a favorite among lab workers, praising the ability to provide illustrations related to raw data, effortless data management, and easy sharing and collaboration with colleagues. Beckman Coulter Life Sciences is uniquely positioned to support laboratories from sample to response when using DURAClone dry reagent technology with the CytoFLEX family of analyzers and the Cytobank data analysis platform. For more information, see https://becls.co/3D1LAYX

Source:

Beckman Coulter Life Sciences

.